THUNDER BAY, ON / ACCESS Newswire / January 12, 2026 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSXV:AIR) ...
TORONTO, ON / ACCESS Newswire / January 8, 2026 / Inventus Mining Corp. (TSXV:IVS) ("Inventus" or the "Company")is ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva’s anti-IL-15 candidate TEV-‘408 TEV- ...
SAINT HELIER, JE / ACCESS Newswire / January 6, 2026 / Caledonia announces that, further to its announcements of December 1, ...
Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and support ...
China and the EU have agreed on price undertaking guidance for Chinese battery electric vehicles (EVs) makers, China's Ministry of Commerce (MOFCOM) announced on Monday, marking a significant step ...
Regions Chief Financial Officer David Turner, left, will retire March 31, 2026, following a nearly 40-year career in auditing ...
TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (“TempraMed” or the “Company”), a medical-technology innovator transforming ...
Royalty funding market reached record high of $10 billion in 2025, powered by synthetic royalties Royalty Pharma maintained industry leadership ...
Last year’s H.R. 1 — also known as the “big beautiful bill” — allocated $50 billion for the federal Rural Health ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva's anti-IL-15 candidate TEV-'408TEV-' ...